This review mainly focus on targeted drug delivery to the colon is extremely desirable for local treatment of inflammatory bowel disease such as ulcerative colitis, crohn's disease, amoebiasis, colonic cancer as well as for systemic delivery of protein and peptide drugs. The colon is a site where local delivery allows topical treatment of inflammatory bowel disease and systemic delivery of drug can take place. Treatment of colon can be made effective if the drug can be targeted directly into the colon because drug release and absorption should not be take in abdomen and the small intestine and bioactive agents should not be degraded and to allow drug release into the colon. Drug targeting to the colonic area is not only associated with the treatment of colonic ailment locally but also delivering drugs such as protein and peptide for their systemic effects which are degraded and bioavailability is very depressed due to the instability in the GI Tract.
INTRODUCTION
Colon targeted drug delivery system may be following the concept of control or sustained route for drug administration has received more attention (Vinay et al., 2012) . At least 50% of the dosage forms available in the market are oral dosage form because these system have more advantage due to high patient compliances (Akhil et al., 2011) Targeted dreg delivery into the colon is highly desirable for local treatment of a variety of bowel disease. Like crohn's disease, colonic cancer ulcerative Colitis, amebiosis and many others disorders ( (Anil and Betty, 2010) . Colon targeted drug delivery system is not only the suitable for delivering the drug to the colon for local treatment but it is also a preferable approach for delivery of protein and peptide and enhance their bioavailability (Amidon et al., 2015) . Bioavailability of protein and peptide may be achieved if it can be protected from acid and enzymes in the stomach and upper intestine and released and absorbed in the colon and protect it form degradation in stomach (Prasanth et al., 2012) . Degradation of such drug in stomach can be prevent by using some polymer either alone or in a combination because polymer effect the rate of release and absorption of drugs and play an important role in formulation of colon targets drug delivery system (H. Rajpurohit et al., 2010) . Oral route is the more preferable and convenient route but other routes for colon drug delivery system may be used. Administration of drug through the rectum offers the shortest route for targeting drugs to the colon still reaching the colon proximal part via rectal administration is difficult. Rectal administration is difficult and painful for patient thus patient compliances decreased (Massimo Campieri et al., 1992) . Colon contain a variety of bacteria which is responsible for azo reduction and enzymatic cleavage which is responsible for the metabolism of many drugs (Sai Mansa et al., 2015)
CHOICE OF POLYMER FOR CTDDS
Delivery of drugs to the colon lead on much interest for local and systemic treatment of variety of colonic disease because of various therapeutic advantage of colon like near neutral and longer transit time. Advantageous delivery of a drug to the colon depend upon protection of the drug from degradation or release in the stomach which can be achieved by using polymer because polymer can influence the rate of release and absorption of drug and have an important role in formulating CTDDS. Both natural and biodegradable polymers are preferred for drug delivery application. 
The digestive system is the collective name used to describe the alimentary canal, its accessory organs and a variety of digestive process. The alimentary canal begin at the mouth, passes through the thorax, abdomen and pelvis and ends at the anus.
The large intestine is about 1.5 meters long, beginning at the caecum in the right iliac fossa and terminating at rectum and anal canal deep in the pelvis. Human large intestine is about 1.5 meter long. the colon is a cylindrical tube which is linked by moist, soft pink lining called mucosa. The colon has four parts which are same structure and function.
Ascending Colon-It is nearly 12.5cm, in length. It extends from the caecum to the hepatic flexure.
Transverse Colon-The ascending colon further continues as the transverse colon, form the hepatic flexure to the splenic future.
Descending Colon-The transverse Colon descends down to form the descending colon. It begins at the splenic mixture and terminates at the beginning of the sigmoid colon.
Sigmoid Colon-The descending colon continue as an S-Shaped Sigmoid colon, terminating at the rectum. Harmful effects:- The bacterial overgrowth in the ileum can developed diarrhea, Mal absorption syndrome and anemia.  The Colonic bacterial flora (some species) can produce ammonia which is not absorbed in hepatic failure and precipitate hepatic encephalopathy
FACTOR AFFECTING COLON TARGETED DRUG DELIVERY SYSTEM
The factors that affect the Colon targeting are categorized in two categories:- Physiological factors  Pharmaceutical factors
PHYSIOLOGICAL FACTORS:-
The factor which involve physiologically in drug delivery and responsible for affecting the targeting of drug to the colon are:-
Gastric emptying (Danda and chandan, 2013)
Drug delivery to the colon upon oral administration depend mainly on gastric emptying and bowel transit time i.e. upon reaching the colon the transit time of drug depends on the nature and size of the particles.
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PRIMARY APPROACHES OF COLON SPECIFIC DRUG DELIVERY-
A. pH Sensitive polymer coated drug delivery system. There is numerous invention approaches have been discovered to develop colon-difference in the pH along the GI tract is one of the approaches to achieve colon targeting. So the polymer has specific solubility at equivalent pH is beneficial for colon targeting however, a pH dependant polymer can shield a formulation in the stomach, and proximal small intestine, it start to dissolve in the colon (Ashish, 2018) . A multiple range of mechanisms have been developed to attain colon targeting of drugs. Mostly used mechanisms are to coat the formulation using natural or synthetic polymer (M. Prathap et al., 2014) . In this mechanism, the drug is intended in the core of the formulation which is coated with PH sensitive Polymer. The first coating is an acid soluble polymer and outer coating is an enteric polymer (Chaurasia and Jain, 2008). The core of formulation is comprised of the API and excipients. When the drug pass through the GI tract the formulation does not degraded or release in the stomach due to enteric coating, but the enteric coating will dissolve in the small intestine, where the PH is above 6. When the drug reaches to the colon, the bacteria enzymetically degrade the polysaccharide into organic acid. This lowers the PH of the surrounding system and causes the dissolution of the surrounding system and results in dissolution of the surrounding system acid soluble coating and subsequent drug release (Neha and S.L., 2013). The most commonly used pH dependent polymers are derivatives of acrylic acid and cellulose (Nishant and Dr. R.C., 2012). (Threveen et al., 2011) . The strategy in designing time released systems is to resist the acidic environment of the stomach and to undergo a lag time of predetermined span of time, after which release of drug take place the lag time in this case is the time required to transit from the mouth to colon a lag time of 5 hours is usually considered sufficient since small intestine is about 3-4 hours, which is relatively constant and hardly affected by the nature of formulation administered. (Mukesh et al., 2013) Disadvantages of this system are- Gastric emptying time varies markedly between subjects or in a manner dependent on type and amount of food intake.  GIT movement would result in the change in gastrointestinal transit of the drug. route of administration which is less acceptable. Microbial triggered delivery system is most convenient and highly site specific approach for targeting drug to the colon than all targeting system. Drug release when the polysaccharides are degraded by the bacteria of the colonic micro flora (Rupali et al., 2015) . The upper part of GIT i.e the stomach and the duodenum has a micro flora of less than 10 3 -10 4 CFU /ml. the micro flora of Colon on the other side is is the range of 10 11 -10 12 CFU/ml consisting mainly of anaerobic bacteria. E.g. Bactericides, Bifid bacteria, Eubacteria, Clostridia Enterococci, Enterobacteria ect. Vast number of enzymes like glucuronidase, xylosidase, arabimosidas, arabimosidase, galactosidase, nitroteductase, azoreductase, deaminase and urea dehydroxylase are produce by micro flora Because of the presence of these biodegradable enzymes, only in the colon, the use of bacterial degradable polymers for colon specific drug delivery seems to be a more site specific approach as compared to other approaches (M. Mallikarjuna et al., 2012).
D. Pro-drug approach for drug delivery to colon
Pro-drug are pharmacologically inactive chemical derivatives that could be used to alter the physiochemical properties of drug in a temporary manner or to increase their usefulness and to decrease associated toxicity. A pro-drug is a compound formed by chemical modification of biologically active compound that will liberate the active compound in vivo by enzymatic or chemical processes (Vimal and Vikram, 2012) . Pro-drug is the main approach of microbial triggered drug delivery system is system in which the drug release from the formulation is triggered by the micro flora present in the gut. (M. Prathap et al., 2014) . Biotransformation is carried out by a variety of enzymes, mainly of bacterial origin, present in the colon. The enzymes that are mainly targeted for colon drug delivery include azoreductase-galactosidase, B-xylsidase, nitroreductases. Generally, a pro-drug is successful as a colon drug carrier of it is hydrophilic and bulky, to minimize absorption from the upper GI tract and once in the colon, it is converted into a more lipophilic drug molecule that is then available for absorption (Threveen et al., 2011) . A clinical study ha shown clear evidence that B-cyclodextrins are poorly digested in the small intestine but are almost completely degraded by the colonic microflora (C. Tuleu et al., 2001 ). Amide linkage
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E. Polysaccharide Based delivery system
Polysaccharide based delivery system is the other form microbial triggered drug delivery system (M. Prathap et al., 2014) . the inability of GIT enzymes to digest certain plant polysaccharides is taken as an advantage to develop colon specific drug delivery system. The drug is embedded in the matrix core of the biodegradable polymer by compressing the blend of active drugs, a degradable the blend of active drugs a degradable polymer and additives (Ravi et al., 2009 ). Many natural polysaccharides such as chondroitin sulphate, pectin, dextran and more particularly guar gum etc. has started with basis of investigation for their potential in innovating colon specific drug delivery. These are led to break down by the colonic micro flora to simple saccharides (Vikash et al., 2015) . They can be easily modified chemically, biochemically and are highly stable, safe, non-toxic, and hydrophilic and in addition are biodegradable. 
NEWLY DEVELOPED APPROACHES FOR CDDS A. Pressure Controlled drug-delivery system
As a result of peristalsis, higher pressures are encountered in the colon than in the small intestine Takaya et al. developed pressure controlled colondelivery capsules prepared using ethyl cellulose, which is insoluble in water (Anil and Betty, 2010) . Peristaltic motion causes the luminal pressure of the large intestine to increase more than that of the small intestine because its contents are more viscous due to the reabsorption of water. Several studies have been carried out to utilize the colonic luminal pressure to pressure to develop colon-specific drug delivery systems (S. Amidon et al., 2015) . the pressure controlled drug delivery system consists of a capsule in which the drug is present. These gelatin capsules are coated with water insoluble polymer like ethylcelluose on their inner side the drug is introduced into the capsule along with suppository base dissolves at body temperature the water from intestinal contents in absorbed resulting in increased viscosity which leads to an increase in the pressure in the capsule expels the drug into the colon (T. Nalanda and Prashant, 2015).
B. Pulsatile colon targeted drug delivery
 Pulsin Cap system  Port system i) Pulsincap System Pulsincap was developed by R.R. Scherer. International Corporation (Michigan) (Vikash et al., 2011) . In this system the formulation is developed in a capsule form. The plug placed in the capsule controls the release of the drug. Swellable hydrogels are used to seal the drug contents. The capsule, gets swelled when it comes in contact with the dissolution fluid and after a lag time the plug gets pushed off from the capsule and the drug will be released (Amit et al., 2015) . Polymers such as different grades of hydroxyl propyl methyl cellulose (HPMC), poly methyl methacrylate and polyvinyl acetate are used as hydrogel plugs. The log time is controlled by the lenth and point of intersection of the plug in the capsule body (Rama et al., 2014).
Diag. 03-PulsinCap system
ii) Port System:
Diag. 04-Plan of Port System
The port system was developed therapeutic system research laboratory Ann Arbor, Michigan, USA, and consist of a capsule coated with a semi-permeable membrane, inside the capsule was an insoluble plug consisting of osmotically active agent and the drug formulation (Vipul and Moinuddin, 2012) . When this capsule came in contact with the dissolution fluid, the semi-permeable membrane allowed the entry of water, which caused the pressure to develop and the insoluble plug expelled after a lag time. This system avoids second time dosing, which was beneficial for school children during daytime (J. Ali et al., 2006) . The lag time is controlled by coating thickness. The system showed good correction in lag time of in-vitro and in-vivo experiments in humans (V.N.L. Sirisha et al., 2012) .
C. CODES technology (combination of PH dependent and microbially triggered CDDS)
CODES was designed to overcome the problems associated systems. In this system both the pH and microbially triggered approach are utilize the controls the drug release at desired location (Vipin et al., 2012 mechanism involving lactulose, which acts as a trigger for site specific drug release in the colon (Vinay et al., 2012) . It consists of core tablets coated with three layer of polymer coatings. The first coating is an acid soluble polymer (eudragit) and outer layer is enteric with a HPMC barrier layer in between to prevent any possible interaction between the oppositively charged polymers (Bhushan et al., 2012) . The premise of the technology is that the enteric coating protects the tablet while it is located on the stomach and then dissolves quickly following gastric emptying. The acid soluble material coating then protects the preparation as it passes through the alkaline PH of the small intestine. Once the tablet arrives in the colon, the bacteria enzymatically degrade the polysaccharide (lactulose) into organic acid. This lowers the PH surrounding the system sufficient to affect the dissolution of the acid soluble coating and subsequent drug release (Anil and Betty, 2010) . The other polysaccharide that are used along with the drug in the core. Tablet are mannitol, maltose etc. The bacteria present in the colon are responsible for the degradation of polysaccharides that are released from the core tablet (Brahma P. et al., 2010) .
Diag. 05-CODES System
D. Osmotic Controlled Drug Delivery (OROS-CT)
Osmotic controlled drug delivery (Alza corporation) is used as a once or twice a day formulation for targeted delivery of drugs to the colon. The OROS-CT can be a single osmotic agent or it can be comprised of as many as five to six push pull osmotic unit filled in a hard gelatin capsule (Brahma et al., 2010) . After coming in contact with GI fluids, the gelatin capsule dissolves and the enteric coating prevents the entry of fluids from stomach into the system (Roop et al., 2014) . The osmotic pumping action results when the coating dissolves in the high pH environment (pH>7) of the small intestine and the drug is delivered out of the orifice at a rate controlled by the rate of water transport across the membrane (K. Raja et al., 2015) .
Diag. 06-OROS-CT
E. Multiparticulate system based drug delivery
Multiparticulate drug delivery systems are mainly oral dosage forms consisting of a multiplicity of small discrete units, each exhibiting some desired characteristics (NS Dey et al., 2008) . The various advantages of this system are increased bioavailability, reduce risk of local irritation, reduce risk of systemic toxicity. The various multiparticulate approaches include pellets, micro particles, granules and nano-particles (Nalanda and Prashant, 2015) . To administer or to recommend total dose these subunits are compressed into a tablets or filled into a sachets or encapsulated. These are capable of protecting the drugs from the chemical and enzymatic degradation in GIT resulting in an increase in their stability and absorption of through the intestinal epithelium (Bipin and Jagdish, 2013).
F. Azo hydrogel
The pH sensitive monomers and azo cross linking agents in the hydrogel produce the colon specificity. During their passage through GIT these hydrogels swell as the pH increase. ii) In vitro enzymatic test-These are 2 tests for the in-vitro enzymatic test.  The carrier drug system is incubated in fermenter containing suitable medium for bacteria. The amount of drug release at different time intervals is determined.  Drug released study is performed in buffer medium containing enzymes pectinase, dextranase or rat or guinea pig or rabbit cecal contents. The amount of drug released in a particular time is directly proportional time is directly proportional to rate of degradation of polymer Carrier (Archana and Divya, 2016).
In -vivo evaluation-
The in-vivo evaluation of the CDDS is done in dogs guinea pigs, rats and pigs as they resemble the anatomic and physiological conditions micro, flora of human GIT the distribution of various enzymes in GIT of rat and rabbit is comparable to that in human. (K. Malleshwari and Vijaya, 2016)
CONCLUSION
Colon targeted drug delivery system provide benefits of local and systemic effects. The main advantage of colon drug delivery system is that the colon offers a long transit time, near neutral PH, reduced enzymatic activity and increased responsiveness to absorption to absorption enhancers. The most critical challenge in CDDS is to preserve the formulation during its passage through the stomach and about six meters of small intestine. After seeking the limitation of different approaches, researchers invented various novel approaches. The novel approaches like pressure controlled drug delivery system, pulsincap system, port system, CODES, multiparticulate system, probiotic approach and azo hydrogels are more specific compared to primary approaches. Both natural and biodegradable polymers are used for the colon specific delivery of the drug. The need of today's business and patient community is to identify the appropriate approach that con result in the delivery of drugs in safe effective and less expensive manner with minimum fluctuation in term of release of drugs at target site.
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